NO146058B - ANALOGUE PROCEDURE FOR THE PREPARATION OF SUBSTITUTED BENZAMIDES. - Google Patents

ANALOGUE PROCEDURE FOR THE PREPARATION OF SUBSTITUTED BENZAMIDES. Download PDF

Info

Publication number
NO146058B
NO146058B NO761977A NO761977A NO146058B NO 146058 B NO146058 B NO 146058B NO 761977 A NO761977 A NO 761977A NO 761977 A NO761977 A NO 761977A NO 146058 B NO146058 B NO 146058B
Authority
NO
Norway
Prior art keywords
methoxy
group
reacted
hydroxyethyl
ethyl
Prior art date
Application number
NO761977A
Other languages
Norwegian (no)
Other versions
NO761977L (en
NO146058C (en
Inventor
Gerard Bulteau
Jacques Acher
Jean-Claude Monier
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of NO761977L publication Critical patent/NO761977L/no
Publication of NO146058B publication Critical patent/NO146058B/en
Publication of NO146058C publication Critical patent/NO146058C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Otolaryngology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Description

Foreliggende oppfinnelse angår en analogifremgangsmåte for fremstilling av nye substituerte benzamider med den generelle formel (I)3 deres kvaternære ammoniumsalter, oksyder, farmaseutisk akseptable syreaddisjonssalter, høyre-og venstredreiende isomerer derav. The present invention relates to an analogous process for the production of new substituted benzamides with the general formula (I)3, their quaternary ammonium salts, oxides, pharmaceutically acceptable acid addition salts, dextrorotatory and levorotatory isomers thereof.

Benzamidene som fremstilles ifølge oppfinnelsen The benzamides produced according to the invention

har formelen: has the formula:

der: there:

A angir en alkylgruppe med 1-4 karbonatomer ; W angir en alkylengruppe med 1-4 karbonatomer; B angir en gruppe med formelen A denotes an alkyl group with 1-4 carbon atoms; W denotes an alkylene group of 1-4 carbon atoms; B denotes a group with the formula

der FL angir en alkylgruppe med 1-5 karbonatomer og R ? en hydroksyalkylgruppe med 1-5 karbonatomer where FL denotes an alkyl group with 1-5 carbon atoms and R ? a hydroxyalkyl group with 1-5 carbon atoms

I IN

eller en 4-hydroksyalkyl-l-piperazinylgruppe, or a 4-hydroxyalkyl-1-piperazinyl group,

eller en gruppe med formelen or a group with the formula

i in

der R er en hydroksyalkylgruppe med 1-5 karbonatomer, en acetyl-gruppe eller en benzhydryloksyalkylgruppe; where R is a hydroxyalkyl group with 1-5 carbon atoms, an acetyl group or a benzhydryloxyalkyl group;

Y angir et hydrogenatom, en nitrogruppe eller aminogruppe; og Y represents a hydrogen atom, a nitro group or an amino group; and

Z angir et hydrogenatom, et halogenatom, en alkylsulfonylgruppe med 1-5 karbonatomer eller en gruppe SC^NR^R^ der R3 og R^ som kan være like "eller forskjellige angir hydrogen eller en lavere alkylgruppe med 1-5 karbonatomer. Z denotes a hydrogen atom, a halogen atom, an alkylsulfonyl group with 1-5 carbon atoms or a group SC^NR^R^ where R 3 and R^ which may be the same or different denote hydrogen or a lower alkyl group with 1-5 carbon atoms.

Benzamidene som fremstilles ifølge oppfinnelsen kan fremstilles ved å omsette en forbindelse med formelen: The benzamides produced according to the invention can be produced by reacting a compound with the formula:

-der D angir en hydroksygruppe eller en organisk rest og A og Y samt Z har den ovenfor angitte betydning, med et amin med den generelle formel (III): -where D denotes a hydroxy group or an organic residue and A and Y as well as Z have the above meaning, with an amine of the general formula (III):

der W og B har den ovenfor angitte betydning, eller ved å omsette deres reaktive derivater. where W and B have the above meaning, or by reacting their reactive derivatives.

I utgangsforbindelsen (II) inkluderer den organiske rest grupper som er i stand til å danne reaktive syrederivater. Disse kan være lavere alkylestere slik som metyl-, etyl-, propyl-, butyl-, isobutyl-, pentyl-, isopentylestere osv., reaktive sure estere slik som cyanometyl- eller metoksymetylestere eller N-hydroksyimidestere, eller eventuelt substituerte aromatiske esterej syrehalogenider; syrehydrazider ; syreazider; symmetriske anhydrider; blandede anhydrider, f.eks. dannet med karbonsyreestere eller halogenmaursyreestere ; azolider slik som triazolider, tetrazolider eller imidazolider; sure isotiocyanater; substitu- In the starting compound (II), the organic residue includes groups capable of forming reactive acid derivatives. These can be lower alkyl esters such as methyl, ethyl, propyl, butyl, isobutyl, pentyl, isopentyl esters, etc., reactive acid esters such as cyanomethyl or methoxymethyl esters or N-hydroxyimide esters, or optionally substituted aromatic esters and acid halides; acid hydrazides; acid azides; symmetrical anhydrides; mixed anhydrides, e.g. formed with carboxylic acid esters or haloformic acid esters; azolides such as triazolides, tetrazolides or imidazolides; acid isothiocyanates; substitute

erte w-trihalogenacetofenoner; substituerte a-oksobenzenaceto-nitriler; benzamider substituert i kjernen. pea w-trihaloacetophenones; substituted α-oxobenzeneacetonitriles; benzamides substituted in the core.

Aminet kan delta i reaksjonen i form av et av sine reaktive derivater som eventuelt kan isoleres. Som eksem- The amine can participate in the reaction in the form of one of its reactive derivatives which can possibly be isolated. As exem-

pel skal nevnes reaksjonsproduktene av aminet med fosforklori- should be mentioned the reaction products of the amine with phosphorus chloride

der, fosforoksyklorid, dialkyl-, diaryl- eller ortofenylenklor-fosfitter, alkyl- eller aryldiklorfosfitter, aminisotiocyanat, der, phosphorus oxychloride, dialkyl, diaryl or orthophenylene chlorophosphites, alkyl or aryl dichlorophosphites, amine isothiocyanate,

det symmetriske eller ikke-symmetriske sulfamid av aminet, the symmetric or unsymmetrical sulfamide of the amine,

det tilsvarende symmetriske urinstoff, og de tilsvarende enami- the corresponding symmetrical urea, and the corresponding enami-

ner. De ovenfor angitte reaktive derivater kan omsettes med syren in situ eller etter foregående isolasjon. down. The above-mentioned reactive derivatives can be reacted with the acid in situ or after previous isolation.

Et er også mulig å gjennomføre reaksjonen mellom It is also possible to carry out the reaction between

den frie syre og fritt amin i nærvær av et kondensasjonsmiddel the free acid and free amine in the presence of a condensing agent

slik som f.eks. silisiumtetraklorid, fosforsyreanhydrid, et karbo-diimid slik som dicykloheksylkarbodiimid, eller alkoksyacetylener slik som metoksy- eller etoksyacetylen. such as e.g. silicon tetrachloride, phosphoric anhydride, a carbodiimide such as dicyclohexylcarbodiimide, or alkoxyacetylenes such as methoxy or ethoxyacetylene.

Amideringsreaksjonen ifølge oppfinnelsen kan gjen-nomføres i nærvær eller i fravær av et oppløsningsmiddel. Sys-temene som benyttes som oppløsningsmiddel er inerte med henblikk The amidation reaction according to the invention can be carried out in the presence or in the absence of a solvent. The systems used as solvents are purposefully inert

på amideringsreaksjonen og er f.eks. alkoholer, polyoler, benzen, toluen, dioksan, kloroform eller dietylenglykoldimetyleter. Det er også mulig å bruke et overskudd av aminet som brukes som ut-gangsstoff som oppløsningsmiddel. Det kan være foretrukket å oppvarme reaksjonsblandingen under amideringen, f.eks. til kokepunktet for det ovenfor angitte oppløsningsmiddel. on the amidation reaction and is e.g. alcohols, polyols, benzene, toluene, dioxane, chloroform or diethylene glycol dimethyl ether. It is also possible to use an excess of the amine used as starting material as a solvent. It may be preferred to heat the reaction mixture during the amidation, e.g. to the boiling point of the above solvent.

Forbindelsene som oppnås ifølge oppfinnelsen, kan The compounds obtained according to the invention can

hvis nødvendig, omsettes med en farmasøytisk akseptabel mineral-syre eller en organisk syre slik saltsyre, bromhydrogensyre, svovelsyre, fosforsyre, oksalsyre, eddiksyre, vinsyre, sitronsyre eller metansulfonsyre for å oppnå syreaddisjonssalter. if necessary, react with a pharmaceutically acceptable mineral acid or an organic acid such as hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, oxalic acid, acetic acid, tartaric acid, citric acid or methanesulfonic acid to obtain acid addition salts.

De kan også, hvis nødvendig, omsettes med et alkylhalogenid eller et sulfat for å oppnå det tilsvarende kvaternære ammoniumsalt. They can also, if necessary, be reacted with an alkyl halide or a sulfate to obtain the corresponding quaternary ammonium salt.

For å illustrere oppfinnelsen gis det nedenfor en To illustrate the invention, a is given below

del utførelseseksempler. share execution examples.

Eksempel 1: N-(l-(2'-hydroksyetyl)-2-pyrrolidinylmetyl)-2-metoksy-5-sulfamoylbenzamid. 48 g etyl-2-metoksy-5-sulfamoylbenzoat, 17 g vann og 32 g 1-(2-hydroksyetyl)-2-aminometylpyrrolidin ble tilsatt til en 250 ml kolbe. Blandingen ble oppvarmet på et vannbad inntil en prøve ble funnet å være totalt oppløselig i fortynnet eddiksyre. Oppløsningen ble avkjølt og deretter fortynnet med 300 ml vann. De dannede krystaller ble filtrert ved avsugning, vasket med vann og tørket ved 40°C. Det oppnådde benzamid ble renset ved omdanning til acetat fulgt av frigjøring av basen. Example 1: N-(1-(2'-hydroxyethyl)-2-pyrrolidinylmethyl)-2-methoxy-5-sulfamoylbenzamide. 48 g of ethyl 2-methoxy-5-sulfamoylbenzoate, 17 g of water and 32 g of 1-(2-hydroxyethyl)-2-aminomethylpyrrolidine were added to a 250 ml flask. The mixture was heated on a water bath until a sample was found to be completely soluble in dilute acetic acid. The solution was cooled and then diluted with 300 ml of water. The formed crystals were filtered by suction, washed with water and dried at 40°C. The benzamide obtained was purified by conversion to acetate followed by liberation of the base.

Det ble oppnådd 39 g N-(1-(2'-hydroksyetyl)-2-pyrro-lidnylmetyl)-2-metoksy-5-sulfamoylbenzamid i et utbytte på 59% og med et smeltepunkt på 135-136°C. Eksempel 2: N-(1-(3'-hydroksypropyl)-2-pyrrolidinylmetyl)-2-■ 39 g of N-(1-(2'-hydroxyethyl)-2-pyrrolidnylmethyl)-2-methoxy-5-sulfamoylbenzamide were obtained in a yield of 59% and with a melting point of 135-136°C. Example 2: N-(1-(3'-hydroxypropyl)-2-pyrrolidinylmethyl)-2-■

metoksy-5-etylsulfonylbenzamidhydroklorid. methoxy-5-ethylsulfonylbenzamide hydrochloride.

38,8 g 2-metoksy-5-etylsulfonylbenzosyremetylester, 13j5 ml vann og 28,4 g l-(3-hydroksypropyl)-2-aminometyl-pyrroli-din ble tilsatt til en 250 ml kolbe. Blandingen ble oppvarmet i 38.8 g of 2-methoxy-5-ethylsulfonylbenzoic acid methyl ester, 13.5 ml of water and 28.4 g of 1-(3-hydroxypropyl)-2-aminomethyl-pyrrolidine were added to a 250 ml flask. The mixture was heated in

.10 timer til 85-90°C. Etteri fordamping ble resten oppløst i 200 ml etanol og oppløsningen ble surgjort til en pH-verdi på 1 med alkoholisk saltsyre. Tetrahydrofuran ble tilsatt og de dannede krystaller ble filtrert, vasket og tørket' i en ovn ved 50°C. Det ble oppnådd 35 g N-(1-(3'-hydroksypropyl)-2-pyrrolidinylmetyl)-2-"-••''metoksy-5-etylsulfonylbenzamidhydrok'lorid 'etter omkrystallisering fra alkohol. Utbyttet var 55, 5% og smeltepunktet l84-l86°C). Eksempel 3'- N- (1' -acetyl-2 ' -pyrrolidinylmetyl)-2-metoksy-5-sul famoylbenzamid. 48 g etyl-2-metoksy-5-sulfamoylbenzoat ble omsatt med 31,5 g N-acetyl-2-amino-metylpyrrolidin på samme måte som angitt ovenfor og dette resulterte i 3^,5 g N-(1'-acetyl-2'-pyrro-lidinylmetyl )-2-metoksy-5-sulfamoylbenzamid i et utbytte på 52,5$ og med et smeltepunkt på 204°C. .10 hours at 85-90°C. After evaporation, the residue was dissolved in 200 ml of ethanol and the solution was acidified to a pH value of 1 with alcoholic hydrochloric acid. Tetrahydrofuran was added and the crystals formed were filtered, washed and dried in an oven at 50°C. 35 g of N-(1-(3'-hydroxypropyl)-2-pyrrolidinylmethyl)-2-"-••''methoxy-5-ethylsulfonylbenzamide hydrochloride were obtained after recrystallization from alcohol. The yield was 55.5% and melting point 184-186°C).Example 3'-N-(1'-acetyl-2'-pyrrolidinylmethyl)-2-methoxy-5-sul famoylbenzamide. 48 g of ethyl-2-methoxy-5-sulfamoylbenzoate was reacted with 31.5 g of N-acetyl-2-amino-methylpyrrolidine in the same manner as stated above and this resulted in 3^.5 g of N-(1'-acetyl- 2'-pyrrolidinylmethyl)-2-methoxy-5-sulfamoylbenzamide in a yield of 52.5$ and with a melting point of 204°C.

Eksempel 4: N,(N,-etyl-N'-(2'-hydroksyetyl)aminoetyl)-2-metoksy-4-amino-5-klorbenzamid. Example 4: N,(N,-ethyl-N'-(2'-hydroxyethyl)aminoethyl)-2-methoxy-4-amino-5-chlorobenzamide.

6,1 g 2-metoksy-4-amino-5-klorbenzosyre og 8 g N-etyl-N-2-hydroksyetyletylendiamin ble tilsatt til en 250 ml kolbe. Blandingen ble oppvarmet til 100°C og det ble tilsatt 6.1 g of 2-methoxy-4-amino-5-chlorobenzoic acid and 8 g of N-ethyl-N-2-hydroxyethylethylenediamine were added to a 250 ml flask. The mixture was heated to 100°C and it was added

6,5 g fosforsyreanhydrid. Blandingen ble forsiktig oppvarmet til 110°C og temperaturen ble deretter hurtig hevet til 150-l60°C. Denne temperatur ble opprettholdt i \ time og deretter, etter av-kjøling til 100°C, ble det tilsatt 100 ml vann. Soda ble tilsatt etter at komponentene totalt var oppløst. Blandingen ble avkjølt og utfellingen ble filtrert, vasket med vann og tørket. Det ble oppnådd 6,6 g N-(N'-etyl-N1 -(2'-hydroksyetyl)aminoetyl)-2-metoksy-4- amino-5-klorbenzamid i et utbytte på 69,8% og med et smeltepunkt på 111-112°C. 6.5 g phosphoric anhydride. The mixture was gently heated to 110°C and the temperature was then rapidly raised to 150-160°C. This temperature was maintained for 1 hour and then, after cooling to 100°C, 100 ml of water was added. Soda was added after the components had completely dissolved. The mixture was cooled and the precipitate was filtered, washed with water and dried. 6.6 g of N-(N'-ethyl-N1-(2'-hydroxyethyl)aminoethyl)-2-methoxy-4-amino-5-chlorobenzamide were obtained in a yield of 69.8% and with a melting point of 111-112°C.

Eksempel 5: N-(1-(2'-benzhydryloksyety1)-2-pyrrolidinylmetyl)-2-metoksy-5-sulfamoylbenzamid. 99 g 1-(2'-benzhydryloksyetyl)-2-aminometylpyrroli-din og 500 ml metyletylketon ble tilsatt en en 4 liters kolbe. Blandingen ble avkjølt til 15°C og en oppløsning av 80 g 2-metoksy-5- sulfamoylbenzoylklorid.i 1500 ml metyletylketon ble tilsatt. Blandingen ble omrørt i 2 timer ved omgivelsestemperatur. Utfellingen som ble dannet, ble filtrert, vasket med en liten mengde metyletylketon og tørket. Hydrokloridet som ble oppnådd ble gjort alkalisk mens det var varmt med ammoniakk, og produktet ble krystallisert ved avkjøling. Krystallene ble filtrert, vasket og tørket i en ovn ved 50°C. Det ble oppnådd 88 g N-(l-(2'-benzhydryloksyetyl)-2-pyrrolidinylmetyl)-2-metoksy-5~sulfamoylbenzamid etter omkrystallisering fra etanol, filtrering gjennom kjønrøk og tørking. Utbyttet var 52,6% og smeltepunktet 124°C. Eksempel 6: 1-(2'-metoksy-4'-nitrobenzamidopropyl)-4-hydroksy-etylpiperazin. 45 g 1-(2'-hydroksyetyl)-4-(3'-aminopropyl)pipera-zin og l80 ml kloroform ble tilsatt til en 1 liters kolbe. En oppløsning av 51 g 2-metoksy-4-nitrobenzoylklorid ble helt i blandingen ved en temperatur på 5-10°C. Ved slutten av tilset-ningen ble blandingen bragt til omgivelsestemperatur og deretter oppvarmet i 1 til 1 1/4 time til 40-45°C. Vann ble tilsatt og kloroformen ble dampet av. Den oppnådde oppløsning ble filtrert ved bruk av kjønrøk og benzamidbasen ble utfelt ved tilsetning av 50g kaliumkarbonat. Etter dekantering ble produktet oppløst i metylklorid og den vandige oppløsning ble ekstrahert med metylenklorid. Example 5: N-(1-(2'-benzhydryloxyethyl)-2-pyrrolidinylmethyl)-2-methoxy-5-sulfamoylbenzamide. 99 g of 1-(2'-benzhydryloxyethyl)-2-aminomethylpyrrolidine and 500 ml of methyl ethyl ketone were added to a 4 liter flask. The mixture was cooled to 15°C and a solution of 80 g of 2-methoxy-5-sulfamoylbenzoyl chloride in 1500 ml of methyl ethyl ketone was added. The mixture was stirred for 2 hours at ambient temperature. The precipitate that formed was filtered, washed with a small amount of methyl ethyl ketone and dried. The hydrochloride obtained was made alkaline while hot with ammonia, and the product crystallized on cooling. The crystals were filtered, washed and dried in an oven at 50°C. 88 g of N-(1-(2'-benzhydryloxyethyl)-2-pyrrolidinylmethyl)-2-methoxy-5-sulfamoylbenzamide were obtained after recrystallization from ethanol, filtration through carbon black and drying. The yield was 52.6% and the melting point 124°C. Example 6: 1-(2'-methoxy-4'-nitrobenzamidopropyl)-4-hydroxyethylpiperazine. 45 g of 1-(2'-hydroxyethyl)-4-(3'-aminopropyl)piperazine and 180 ml of chloroform were added to a 1 liter flask. A solution of 51 g of 2-methoxy-4-nitrobenzoyl chloride was poured into the mixture at a temperature of 5-10°C. At the end of the addition, the mixture was brought to ambient temperature and then heated for 1 to 1 1/4 hours to 40-45°C. Water was added and the chloroform was evaporated. The solution obtained was filtered using carbon black and the benzamide base was precipitated by adding 50g of potassium carbonate. After decantation, the product was dissolved in methyl chloride and the aqueous solution was extracted with methylene chloride.

Den organiske fase ble tørket med kaliumkarbonat og metylenkloridet ble deretter destillert av i vakuum. Det olje-lignende benzamid som ble oppnådd ble renset ved dannelse av hydrokloridet og behandling' med ammoniakk. The organic phase was dried with potassium carbonate and the methylene chloride was then distilled off in vacuo. The oil-like benzamide obtained was purified by formation of the hydrochloride and treatment with ammonia.

Det ble oppnådd 59 g 1-(2'-metoksy-4'-nitrobenza-midopropyl )-4-hydroksyetylpiperazin i form av en olje og i et utbytte på 67,2%. Renhetsanalyse ved kvantitativ -bestemmelse i et ikke-vandig medium med perklorsyre ga 97,8%. 59 g of 1-(2'-methoxy-4'-nitrobenzamidopropyl)-4-hydroxyethylpiperazine were obtained in the form of an oil and in a yield of 67.2%. Purity analysis by quantitative determination in a non-aqueous medium with perchloric acid gave 97.8%.

Eksempel 7: N-(1-(2'-hydroksyetyl)-2-pyrrolidinylmetyl)-2-metoksy-5-etylsulfonylbenzamidhydroklorid. Example 7: N-(1-(2'-hydroxyethyl)-2-pyrrolidinylmethyl)-2-methoxy-5-ethylsulfonylbenzamide hydrochloride.

39 g l-(2-hydroksyetyl)-2-aminometylpyrrolidin, 250 ml metyletylketon og under opprettholdelse av temperaturen, mellom 5 og 10°C, 70 g 2-metoksy-5-etylsulfonylbenzoylklorid ble tilsatt til en 500 ml kolbe. Etter i omrøring over natt ble det krystall-inske produkt filtrert ved undertrykk, vasket med metyletylketon og tørket ved 45°C. Råproduktet ble omkrystallisert i 200 ml alkohol ved 95°C. Det ble oppnådd 73 g N-(l-(-2 '-hydroksyetyl)-2- pyrrolidinylmetyl)-2-metoksy-5-etylsulfonylbenzamidhydroklorid i et utbytte på 66, 5% og med et smeltepunkt på 175-178°C. Eksempel 8: N-(N'-etyl-N'-(2'-hydroksyetyl)-aminoetyl)-2-metoksy- 5-sul-f amoylbenzamid. 78 g etyl-2-rne<t>oks<y>-5-sulf amoylbenzoat, 27 ml vann og en 51 g N-éty-l-N-hydroksyetyletylendiamin ble tilsatt til en 250 mi" kolbe. Blandingen ble oppvarmet i 10 timer på et vannbad. Oppløsningen ble fortynnet og benzamidbasen deretter krystallisert,. Denne ..ble renset ved dannelse av hydrokloridet og utfelling av basen med 'ammoniakk. De oppnådde krystaller ble filtrert ved sug , vasket med vann til kloridionene alle var fjernet, og tørket i en ovn ved 40°C. 39 g of 1-(2-hydroxyethyl)-2-aminomethylpyrrolidine, 250 ml of methyl ethyl ketone and, maintaining the temperature, between 5 and 10°C, 70 g of 2-methoxy-5-ethylsulfonylbenzoyl chloride were added to a 500 ml flask. After stirring overnight, the crystalline product was filtered under reduced pressure, washed with methyl ethyl ketone and dried at 45°C. The crude product was recrystallized in 200 ml of alcohol at 95°C. 73 g of N-(1-(-2'-hydroxyethyl)-2- pyrrolidinylmethyl)-2-methoxy-5-ethylsulfonylbenzamide hydrochloride in a yield of 66.5% and with a melting point of 175-178°C. Example 8: N-(N'-ethyl-N'-(2'-hydroxyethyl)-aminoethyl)-2-methoxy- 5-sul-f amoylbenzamide. 78 g of ethyl-2-rne<t>ox<y>-5-sulfamoylbenzoate, 27 ml of water and a 51 g of N-ethyl-1-N-hydroxyethylethylenediamine were added to a 250 ml" flask. The mixture was heated for 10 hours at a water bath. The solution was diluted and the benzamide base then crystallized. This ..was purified by formation of the hydrochloride and precipitation of the base with ammonia. The crystals obtained were filtered by suction, washed with water until the chloride ions were all removed, and dried in a oven at 40°C.

Det ble oppnådd 66 g N-(N'-etyl-N'-(2'-hydroksy-etyl )aminoetyl)-2-metoksy-5-sulfamoylbenzamid i et utbytte på' 64% og med et smeltepunkt på<:>149-150°C. 66 g of N-(N'-ethyl-N'-(2'-hydroxy-ethyl)aminoethyl)-2-methoxy-5-sulfamoylbenzamide were obtained in a yield of 64% and with a melting point of <:>149 -150°C.

Eksempel 9: N-(l-(3'-hydroksypropyl)-2-pyrrolidinylmetyl)-2-metoksy-5-sulfamoylbenzamidhydroklorid. Example 9: N-(1-(3'-hydroxypropyl)-2-pyrrolidinylmethyl)-2-methoxy-5-sulfamoylbenzamide hydrochloride.

38,9 g etyl-2-metoksy-5-sulfamoylbenzoat, 13,5 ml vann og 28,4 g N-l-(3'-hydroksypropyl)-2-aminometylpyrrolidin ble tilsatt til en 250 ml kolbe. Blandingen ble oppvarmet i 10 timer ved 80°C og etter avkjøling ble 100 ml benzen tilsatt og oppløsningsmidlene ble destillert av. Blandingen ble avkjølt og 500 ml vann ble deretter tilsatt. De dannede krystaller ble fil- 38.9 g of ethyl 2-methoxy-5-sulfamoylbenzoate, 13.5 ml of water and 28.4 g of N-1-(3'-hydroxypropyl)-2-aminomethylpyrrolidine were added to a 250 ml flask. The mixture was heated for 10 hours at 80°C and after cooling, 100 ml of benzene was added and the solvents were distilled off. The mixture was cooled and 500 ml of water was then added. The formed crystals were fil-

trert av, vasket med vann og tørket i en ovn ved 50°C. stripped, washed with water and dried in an oven at 50°C.

Det ble oppnådd 40 g N-(1-(3'-hydroksypropyl) -2-pyrrolidinylmetyl)-2-metoksy-5-sulfamoylbenzamid med et utbytte på 72%. 40 g of N-(1-(3'-hydroxypropyl)-2-pyrrolidinylmethyl)-2-methoxy-5-sulfamoylbenzamide were obtained with a yield of 72%.

Benzamidet ble omdannet til hydrokloridet ved opp-løsning i absolutt alkohol og behandling med 50 ml 25%-ig etanol-isk .saltsyre. Det faste stoff som ble oppnådd ble.omkrystallisert fra metylalkohol. The benzamide was converted to the hydrochloride by dissolution in absolute alcohol and treatment with 50 ml of 25% ethanolic hydrochloric acid. The solid obtained was recrystallized from methyl alcohol.

Det ble oppnådd 38 g N-(1-(3'-hydroksypropyl)-2-pyrrolidinylmetyl)-2-metoksy-5^sulfamoylbenzamidhydroklorid i et 38 g of N-(1-(3'-hydroxypropyl)-2-pyrrolidinylmethyl)-2-methoxy-5-sulfamoylbenzamide hydrochloride were obtained in a

utbytte på .62,2% og med et smeltepunkt på 226-229°C. Eksempel 10: l--.( 2 ' -metoksy-4 ' -amino-benzamidopropyl) -4-h'ydroksy-etylpiperazindifosfat. yield of .62.2% and with a melting point of 226-229°C. Example 10: 1-(2'-methoxy-4'-amino-benzamidopropyl)-4-hydroxyethylpiperazine diphosphate.

2,8 g 2-metoksy-4-åminobenzosyre, 3,^ g l-(2 '-hydroksy-etyl )-4-(3'-aminopropyl)piperazin og 60 ml pyridin ble tilsatt til en 250 ml kolbe og 2,3 g silisiumtetraklorid ble tilsatt. dråp.evis. Blandingen ble oppvarmet i 3 timer ved tilbakeløpstemperatur. 2.8 g of 2-methoxy-4-aminobenzoic acid, 3.5 g of 1-(2'-hydroxyethyl)-4-(3'-aminopropyl)piperazine and 60 ml of pyridine were added to a 250 ml flask and 2, 3 g of silicon tetrachloride was added. death.news. The mixture was heated for 3 hours at reflux temperature.

Pyridinet ble destillert av i vakuum. Det ble tilsatt 30 ml vann fulgt av saltsyre inntil pH-verdien var 1. Blandingen ble oppvarmet til kokepunktet, filtrert etter undersøkelse,at pH-verdien fremdeles var sur, hvoretter ammoniakk ble tilsatt mens blandingen ennu var varm. The pyridine was distilled off in vacuo. 30 ml of water was added followed by hydrochloric acid until the pH was 1. The mixture was heated to the boiling point, filtered after checking that the pH was still acidic, after which ammonia was added while the mixture was still hot.

Etter avkjøling ble væsken dekantert fra bunnfallet. Det ble oppnådd 3,9 g 1-(2'-metoksy-4'-åminobenza-midopropyl)-4-hydroksyetylpiperazin i . et utbytte- på 69,65. After cooling, the liquid was decanted from the precipitate. 3.9 g of 1-(2'-methoxy-4'-aminobenzamidopropyl)-4-hydroxyethylpiperazine were obtained in . a dividend of 69.65.

Renhetsundersøkelse ved kvantitativ bestemmelse i ikke-vandig medium viste 97,5%. Purity examination by quantitative determination in a non-aqueous medium showed 97.5%.

Den oppnådde base ble oppløst i alkohol og deretter omdannet til det tilsvarende fosfat med fosforsyre.. Det oppnådde fosfat var et dobbeltfosfat som krystalliserte med 3 mol vann. The base obtained was dissolved in alcohol and then converted to the corresponding phosphate with phosphoric acid. The phosphate obtained was a double phosphate which crystallized with 3 mol of water.

'Det' ble oppnådd 3,2 g 1-(2'-metoksy-4'-aminobenzamidopropyl)-4-hydroksyetylpiperazindifosfat med et smeltepunkt på l44-l45°C. 'There' was obtained 3.2 g of 1-(2'-methoxy-4'-aminobenzamidopropyl)-4-hydroxyethylpiperazine diphosphate with a melting point of 144-145°C.

Benzamidene som fremstilles ifølge oppfinnelsen The benzamides produced according to the invention

har verdifulle terapeutiske egenskaper, spesielt som antieme-tika. Deres lave toksisitet tillater bruk i humanterapi uten risiko for sidevirkninger. has valuable therapeutic properties, especially as an antiemetic. Their low toxicity allows use in human therapy without the risk of side effects.

Den akutte toksisitet for de fremstilte produktene ble bestemt på mus på parenteral måte (endovenøs eller intraperitonealt). LD^-verdiene, beregnet ifølge Behrens og The acute toxicity of the manufactured products was determined in mice parenterally (endovenously or intraperitoneally). The LD^ values, calculated according to Behrens et

Karber, er angitt i følgende tabell: Carbs, are listed in the following table:

Den antiemetiske virkning for produktene som fremstilles i for- motvirkning av apomorfin - ble undersøkt på hunder ifølge Chen og Ensor slik denne teknikk var utviklet av Ducrot The antiemetic effect of the products which are prepared in the form of apomorphine - was investigated in dogs according to Chen and Ensor as this technique was developed by Ducrot

og Decourt. and Decourt.

'Resultatene som ble oppnådd er sammenlignet med de som ble oppnådd av Courvoisier for fenotiaziner og med de som ble oppnådd av Schallek for trimetobenzamid, og er angitt i følg-ende tabell. Aktivitetsindeksen er beregnet på subkutan måte med klorpromazin som referansestoff. The results obtained are compared with those obtained by Courvoisier for phenothiazines and with those obtained by Schallek for trimethobenzamide, and are given in the following table. The activity index is calculated subcutaneously with chlorpromazine as reference substance.

Disse resultater angir at .'forbindelsene som fremstilles mérkbårt er mere 'aktive som antiemétika'enn feridtiå-ziner og trimetobenzamid. These results indicate that the compounds produced are significantly more active as antiemetics than ferridthiazines and trimethobenzamide.

Claims (11)

1. Analogifremgangsmåte for fremstilling av terapeu-tisk aktive substituerte benzamider, kvaternære ammoniumsalter, oksyder, syreaddisjonssalter med farmasøytisk akseptable syrer samt høyre- og venstredreiende isomerer derav, med formelen: der : A angir en alkylgruppe med 1-4 karbonatomer; W angir en alkylengruppe med 1-4 karbonatomer; ' B angir en gruppe med formelen der R^ angir en alkylgruppe med 1-5 karbonatomer og Yi^ en hydroksylalkylgruppe med! 1-5 karbonatomer eller en 4-hydroksylalkyl-l-piperazinylgruppe, eller' en gruppe méd formelen der R er en hydroksylalkylgruppe med 1-5 karbonatomer, en acetylgryppe eller en benzhydryloksylalkylgruppe; Y angir et hydrogenatom, en nitrogruppe eller aminogruppe; og Z angir et hydrogenatom, et halogenatom, en alkylsulfonylgruppe med 1-5 karbonatomer eller en gruppe SO^NR^R^ der R^ og R^ som kan være like eller forskjellige angir hydrogen eller en lavere alkylgruppe med 1-5 karbonatomer,karakterisert ved at en forbindelse mad. formelen: der D angir en hydroksygruppe eller en organisk rest og A,Y og Z har den ovenfor angitte betydning, omsettes med et amin med den generelle formel: hvori W og B har den ovenfor angitte betydning, eller ved om-setning av de tilsvarende reaktive derivater.1. Analogy process for the production of therapeutically active substituted benzamides, quaternary ammonium salts, oxides, acid addition salts with pharmaceutically acceptable acids and dextrorotatory and levorotatory isomers thereof, with the formula: where: A denotes an alkyl group with 1-4 carbon atoms; W denotes an alkylene group of 1-4 carbon atoms; ' B denotes a group with the formula where R^ denotes an alkyl group with 1-5 carbon atoms and Yi^ a hydroxylalkyl group with! 1-5 carbon atoms or a 4-hydroxyalkyl-1-piperazinyl group, or' a group with the formula where R is a hydroxylalkyl group with 1-5 carbon atoms, an acetyl group or a benzhydryloxylalkyl group; Y represents a hydrogen atom, a nitro group or an amino group; and Z represents a hydrogen atom, a halogen atom, an alkylsulfonyl group with 1-5 carbon atoms or a group SO^NR^R^ where R^ and R^ which may be the same or different denote hydrogen or a lower alkyl group with 1-5 carbon atoms, characterized in that a compound mad. the formula: where D denotes a hydroxy group or an organic residue and A, Y and Z have the meaning given above, is reacted with an amine of the general formula: in which W and B have the meaning indicated above, or by conversion of the corresponding reactive derivatives. 2. - Analogifremgangsmåte ifølge krav 1 for fremstilling av N-(1-(2'-hydroksyetyl) - 2-pyrrolidinylmetyl)-2-metoksy-5_ sulfamoylbenzamid, karakterisert ved at etyl-2-metoksy-5~sulfamoylbenzoat omsettes med 1-(2-hydroksyetyl)-2-aminometylpyrrolidin. ..<.>..<...>.2. - Analogous method according to claim 1 for the production of N-(1-(2'-hydroxyethyl)-2-pyrrolidinylmethyl)-2-methoxy-5-sulfamoylbenzamide, characterized in that ethyl 2-methoxy-5-sulfamoylbenzoate is reacted with 1- (2-hydroxyethyl)-2-aminomethylpyrrolidine. ..<.>..<...>. 3. Analogifremgangsmåte ifølge krav 1 for fremstilling av N-(1-(3'-hydroksypropyl)-2-pyrrolidinylmetyl)-2-metoksy-5-etylsulfonylbenzamidhydroklorid, karakterisert ved at 2-metoksy-5~etylsulfonylbenzosyremetylester omsettes med 1-(3-hydroksypropyl)-2-aminometyl-pyrrolid'in méd étterføl-' gende omdanning til hydroklorid.3. Analogous process according to claim 1 for the production of N-(1-(3'-hydroxypropyl)-2-pyrrolidinylmethyl)-2-methoxy-5-ethylsulfonylbenzamide hydrochloride, characterized in that 2-methoxy-5-ethylsulfonylbenzoic acid methyl ester is reacted with 1-(3 -hydroxypropyl)-2-aminomethyl-pyrrolidine with subsequent conversion to hydrochloride. 4. Analogifremgangsmåte ifølge krav 1 for fremstilling av N-(1'-acetyl-2'-pyrrolidinylmetyl)-2-metoksy-5~sulfamoylbenzamid, karakterisert ved at etyl-2-metoksy-5-sulfamoylbenzoat omsettes med N-acetyl-2-aminb-metylpyrroli- .din.4. Analogous method according to claim 1 for the production of N-(1'-acetyl-2'-pyrrolidinylmethyl)-2-methoxy-5-sulfamoylbenzamide, characterized in that ethyl 2-methoxy-5-sulfamoylbenzoate is reacted with N-acetyl-2 -amineb-methylpyrrolidine-.din. 5. Analogifremgangsmåte ifølge krav 1 for fremstil- -.;, ling av N-(N'-etyl-N'-hydroksyetylFaminoetyl)-2-metoksy-4-amino-5-klorbenzamid, karakterisert ved' at 2-metoksy-4-amino-5-klorbenzosyre omsettes med N-etyl-N-2-hydroksyetylendiamin.5. Analogous process according to claim 1 for the preparation of N-(N'-ethyl-N'-hydroxyethylaminoethyl)-2-methoxy-4-amino-5-chlorobenzamide, characterized in that 2-methoxy-4 -amino-5-chlorobenzoic acid is reacted with N-ethyl-N-2-hydroxyethylenediamine. 6. Analogifremgangsmåte ifølge krav 1 for fremstilling av N- (1-(2 '. -benzhydryloksyetyl)-2-pyrrolidinylmetyl)-2-metoksy-5-sulfamoylbenzamid, karakterisert ved at 1-(2'-benzhydryloksyetyl)-2-aminometylpyrrolidin omsettes med 2-metoksy-5~sulfamoylbenzoylklorid.6. Analogous method according to claim 1 for the production of N-(1-(2'.-benzhydryloxyethyl)-2-pyrrolidinylmethyl)-2-methoxy-5-sulfamoylbenzamide, characterized in that 1-(2'-benzhydryloxyethyl)-2-aminomethylpyrrolidine is reacted with 2-methoxy-5-sulfamoylbenzoyl chloride. 7. Analogifremgangsmåte ifølge krav 1 for fremstilling av 1-(2'-metoksy-4'-nitrobenzamidopropyl)-4-hydroksyetyl-piperazin, karakterisert ved at l-(2'-hydroksyetyl)-4-(3'-aminopropyl)piperazin omsettes med 2-metoksy-4-nitrobenzoylklorid.7. Analogous method according to claim 1 for the production of 1-(2'-methoxy-4'-nitrobenzamidopropyl)-4-hydroxyethyl-piperazine, characterized in that 1-(2'-hydroxyethyl)-4-(3'-aminopropyl)piperazine is reacted with 2-methoxy-4-nitrobenzoyl chloride. 8. Analogifremgangsmåte ifølge krav 1 for fremstilling av N-(1-(2'-hydroksyetyl)-2-pyrrolidinylmetyl)-2-metoksy-5-etylsulfonylbenzamidhydrokloridj karakterisert ved at 1-(2-hydroksyetyl)-2-aminometylpyrrolidin omsettes med 2-metoksy-5-etylsulfonylbenzoylklorid med etterfølgende omdanning til hydroklorid. 8. Analogous process according to claim 1 for the production of N-(1-(2'-hydroxyethyl)-2-pyrrolidinylmethyl)-2-methoxy-5-ethylsulfonylbenzamide hydrochloridej characterized in that 1-(2-hydroxyethyl)-2-aminomethylpyrrolidine is reacted with 2 -methoxy-5-ethylsulfonylbenzoyl chloride with subsequent conversion to hydrochloride. 9- Analogifremgangsmåte ifølge krav 1 for fremstilling av N-(N'-etyl-N'-(2'-hydroksyetyl)aminoetyl)-2-metoksy-5-sulfamoylbenzamid, karakterisert ved at etyl-2-metoksy-5~sulfamoylbenzoat omsettes med N-etyl-N-hydroksyetyletylendiamin. 9- Analogous method according to claim 1 for the preparation of N-(N'-ethyl-N'-(2'-hydroxyethyl)aminoethyl)-2-methoxy-5-sulfamoylbenzamide, characterized in that ethyl 2-methoxy-5-sulfamoylbenzoate is reacted with N-ethyl-N-hydroxyethylethylenediamine. 10. Analogifremgangsmåte ifølge krav 1 for fremstilling av N-(1-(3'-hydroksypropyl)-2-pyrrolidinylmetyl)-2-metoksy-5-sulfamoylbenzamid, karakterisert ved at etyl-2-metoksy-5~sulfamoylbenzoat omsettes med N-l-(3'-hydroksy-propyl )-2-aminometylpyrrolidin. 10. Analogous process according to claim 1 for the production of N-(1-(3'-hydroxypropyl)-2-pyrrolidinylmethyl)-2-methoxy-5-sulfamoylbenzamide, characterized in that ethyl 2-methoxy-5-sulfamoylbenzoate is reacted with N-1- (3'-Hydroxy-propyl)-2-aminomethylpyrrolidine. 11. Analogifremgangsmåte ifølge krav 1 for fremstilling av 1-(2'-metoksy-4'-aminobenzamidopropy1)-4-hydroksyetyl-piperazinedifosfat, karakterisert ved at 2-metoksy-4-aminobenzosyre omsettes med 1-(2'-hydroksyetyl)-4-(3'-aminopropyl)piperazin med etterfølgende omdanning til difosfat.11. Analogous method according to claim 1 for the production of 1-(2'-methoxy-4'-aminobenzamidopropyl)-4-hydroxyethyl-piperazine diphosphate, characterized in that 2-methoxy-4-aminobenzoic acid is reacted with 1-(2'-hydroxyethyl)- 4-(3'-aminopropyl)piperazine with subsequent conversion to diphosphate.
NO761977A 1975-06-10 1976-06-09 ANALOGY PROCEDURE FOR THE PREPARATION OF SUBSTITUTED BENZAMIDES NO146058C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7518001A FR2313935A1 (en) 1975-06-10 1975-06-10 NEW BENZAMIDES SUBSTITUTES, THEIR DERIVATIVES AND THEIR PREPARATION PROCESS

Publications (3)

Publication Number Publication Date
NO761977L NO761977L (en) 1976-12-13
NO146058B true NO146058B (en) 1982-04-13
NO146058C NO146058C (en) 1982-07-28

Family

ID=9156239

Family Applications (1)

Application Number Title Priority Date Filing Date
NO761977A NO146058C (en) 1975-06-10 1976-06-09 ANALOGY PROCEDURE FOR THE PREPARATION OF SUBSTITUTED BENZAMIDES

Country Status (37)

Country Link
JP (1) JPS6055503B2 (en)
AR (1) AR210888A1 (en)
AT (1) AT358571B (en)
AU (1) AU506001B2 (en)
BE (1) BE842059A (en)
BG (1) BG27360A3 (en)
CA (1) CA1064930A (en)
CH (1) CH596175A5 (en)
CS (1) CS189007B2 (en)
DD (1) DD124380A5 (en)
DE (1) DE2623075A1 (en)
DK (1) DK255276A (en)
EG (1) EG12285A (en)
ES (1) ES448643A1 (en)
FI (1) FI761669A (en)
FR (1) FR2313935A1 (en)
GB (1) GB1500105A (en)
HK (1) HK46979A (en)
HU (1) HU172195B (en)
IE (1) IE43375B1 (en)
IN (1) IN142899B (en)
LU (1) LU75104A1 (en)
MW (1) MW1676A1 (en)
MX (1) MX3580E (en)
NL (1) NL186382C (en)
NO (1) NO146058C (en)
NZ (1) NZ181072A (en)
OA (1) OA05350A (en)
PH (1) PH13912A (en)
PL (2) PL103075B1 (en)
PT (1) PT65164B (en)
RO (1) RO70265A (en)
SE (1) SE415971B (en)
SU (2) SU607551A3 (en)
YU (1) YU39352B (en)
ZA (1) ZA763042B (en)
ZM (1) ZM6576A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ186175A (en) * 1977-01-27 1980-03-05 Shionogi & Co Meta-sulphonamidobenzamide derivatives
FR2415099A1 (en) * 1978-01-20 1979-08-17 Ile De France NEW DERIVATIVES OF 4-AMINO-5-ALKYLSULFONYL ORTHO-ANISAMIDES, THEIR METHODS OF PREPARATION AND THEIR APPLICATION AS PSYCHOTROPES
FR2438650A1 (en) * 1978-10-11 1980-05-09 Ile De France N- (1-METHYL 2-PYRROLIDINYL METHYL) 2,3-DIMETHOXY 5-METHYLSULFAMOYL BENZAMIDE AND DERIVATIVES THEREOF, THEIR PREPARATION METHODS AND THEIR APPLICATION IN THE TREATMENT OF LOWER URINARY DISORDERS
JPS597160A (en) * 1982-06-28 1984-01-14 ラボラトリーオス・デラグランヘ・エセ・ア N-(1-propyl-2-pyrrolidinylmethyl)-2-methoxy-5- sulfamoylbenzamide, manufacture and antidepressive
US4820715A (en) * 1984-06-28 1989-04-11 Bristol-Myers Company Anti-emetic quinuclidinyl benzamides
US4808624A (en) * 1984-06-28 1989-02-28 Bristol-Myers Company Pharmacologically active substituted benzamides
US5011992A (en) * 1984-06-28 1991-04-30 Bristol-Myers Squibb Company Pharmacologically active substituted benzamides
JP3026845B2 (en) * 1991-02-20 2000-03-27 日清製粉株式会社 Piperidine derivative
US9375486B2 (en) 2012-09-17 2016-06-28 Nektar Therapeutics Oligomer-containing benzamide-based compounds

Also Published As

Publication number Publication date
ATA400176A (en) 1980-02-15
CA1064930A (en) 1979-10-23
EG12285A (en) 1978-09-30
PH13912A (en) 1980-11-04
MW1676A1 (en) 1977-10-12
ZA763042B (en) 1977-04-27
CH596175A5 (en) 1978-02-28
PT65164A (en) 1976-07-01
DD124380A5 (en) 1977-02-16
PL102929B1 (en) 1979-05-31
YU39352B (en) 1984-10-31
FI761669A (en) 1976-12-11
IN142899B (en) 1977-09-03
AR210888A1 (en) 1977-09-30
MX3580E (en) 1981-03-19
RO70265A (en) 1981-06-30
AU1436076A (en) 1977-12-01
BE842059A (en) 1976-11-22
DK255276A (en) 1976-12-11
NO761977L (en) 1976-12-13
OA05350A (en) 1981-02-28
GB1500105A (en) 1978-02-08
ES448643A1 (en) 1977-07-01
SE415971B (en) 1980-11-17
JPS5231041A (en) 1977-03-09
NZ181072A (en) 1978-07-28
AU506001B2 (en) 1979-12-13
NO146058C (en) 1982-07-28
PL103075B1 (en) 1979-05-31
ZM6576A1 (en) 1977-06-21
SU607551A3 (en) 1978-05-15
IE43375B1 (en) 1981-02-11
IE43375L (en) 1976-12-10
NL186382B (en) 1990-06-18
NL186382C (en) 1990-11-16
SE7606424L (en) 1976-12-11
DE2623075A1 (en) 1976-12-30
JPS6055503B2 (en) 1985-12-05
NL7606284A (en) 1976-12-14
PL190247A1 (en) 1978-03-13
SU645557A3 (en) 1979-01-30
BG27360A3 (en) 1979-10-12
HU172195B (en) 1978-06-28
PT65164B (en) 1977-11-17
YU131876A (en) 1982-06-30
CS189007B2 (en) 1979-03-30
HK46979A (en) 1979-07-20
LU75104A1 (en) 1977-03-09
AT358571B (en) 1980-09-25
FR2313935A1 (en) 1977-01-07
FR2313935B1 (en) 1979-04-27

Similar Documents

Publication Publication Date Title
FI59990C (en) FOERFARANDE FOER FRAMSTAELLNING AV PAO CENTRALNERVSYSTEMET VERKANDE RACEMISKA ELLER OPTISKT ACTIVE ARYLPIPERAZINER SAMT DERAS SYRAADDITIONSSALTER
US3819639A (en) 2-metatrifluoromethylanilino-pyridine-5-n-acetyl sulfonamide
NO155805B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVITY 2- (4- (DIPHENYLMETHYL) -1-PIPERAZINYL) -ACDIC ACIDS AND THEIR AMIDS AND NON-TOXIC SALTS.
US4029673A (en) N-(1-benzyl pyrrolidinyl 2-alkyl) substituted benzamides and derivatives thereof
EP0427765A1 (en) Alkoxy-4(1h)-pyridone derivatives, processes for preparing them and their use as drugs
SU543341A3 (en) Method for preparing benzylamine derivatives or their salts
CN109232541B (en) Prolyl hydroxylase and histone deacetylase dual inhibitor and preparation method and application thereof
CA1092111A (en) Sulfonamido-benzoic acid derivatives and process for the preparation thereof
NO146058B (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF SUBSTITUTED BENZAMIDES.
SU548207A3 (en) The method of obtaining derivatives of 2-arylamino-2-imidazoline or their salts
AU644295B2 (en) 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their use in therapeutics
US2765338A (en) New aliphatic acid amide derivatives and processes for the production thereof
US4578465A (en) Phenyliperazine derivatives
IE902845A1 (en) New oxazolopyridine derivatives, process for preparing them¹and pharmaceutical compositions containing them
NO124430B (en)
IE921319A1 (en) 2-aminopyrimidine-4-carboxamide derivatives, their¹preparation and their application in therapy
NO750713L (en)
US3970661A (en) 2-Amino, 5-carbamoyl pyridine compounds
US5198441A (en) Derivatives of 1,2-dihydro 2-oxo quinoxalines, their preparation and their use in therapy
US3225091A (en) Anticholinergic substituted butyramides
US5179089A (en) Isoquinoline compounds, compositions and use
US3969356A (en) N-[3-(p-f-benzoyl)-propyl]-N&#39;-[2.(nitro,nitro-el, or methoxyphenyl)-ethyl]-p
KR810000357B1 (en) Process for preparing substituted benzamides
CA1322755C (en) Acetamide compounds
SU523634A3 (en) Method for preparing benzylamine derivatives or their salts